Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹281 Cr
verified against source
Revenue YoY
13%
reported change
EBITDA
₹22 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Excel Industries reported Q4 FY26 standalone revenue of ₹281 crore (+13% YoY) and adjusted EBITDA of ₹22 crore (+13% YoY), with margins flat at 8%. PAT plunged to ₹3 crore from ₹11 crore last year, reflecting higher depreciation and other costs. The agrochemical segment faced headwinds from extended monsoons and channel inventory, partially offset by strength in YP derivatives and performance solutions. Management flagged near-term uncertainty from El Niño and raw material volatility, declining to provide forward guidance. A shareholder expressed frustration over stagnant stock price and lack of value creation. Risks include potential anti-dumping duty impact on HDP/ATMP, raw material pass-through challenges, and suboptimal monsoon affecting agro demand.
Colored figures show movement against the previous available record.
Guidance to track
- Management plans to deploy ₹200-300 crore in capex over the next 2-3 years, targeting fixed asset turnover of 1-1.5x and ROI of 15-20%.
- The company plans to launch one more biocide product in the second half of FY27 to enhance product offerings.
- The dedicated line for the contract manufacturing agreement announced in November 2025 is expected to be commissioned by July 2026.
Risks flagged
- Management cited uncertainty in agrochemical intermediates demand due to potential suboptimal monsoon from El Niño forecast.
- Geopolitical developments are causing raw material availability and price challenges; while recent increases were passed on, future pass-through is uncertain.
- The DGTR anti-dumping case for HDP and ATMP could impact revenue; preliminary findings expected by September 2026 but quantum unknown.
- A long-term shareholder expressed disappointment over stagnant revenue and stock price, questioning management's focus on value creation.
Key quotes
- If we have to describe this company in one word that word is stagnation.
- Given the overall uncertainty and volatility, it is not possible to make any forward statements.
- We are planning to deploy capex... we have also given an indication broadly as to what we believe would be the fixed asset turnover from this kind of capex.
Research modules